Frontiers in agingPub Date : 2024-10-23eCollection Date: 2024-01-01DOI: 10.3389/fragi.2024.1486281
Jia Chen, Hongyu Li, Yongyin Huang, Qiang Tang
{"title":"The role of high mobility group proteins in cellular senescence mechanisms.","authors":"Jia Chen, Hongyu Li, Yongyin Huang, Qiang Tang","doi":"10.3389/fragi.2024.1486281","DOIUrl":"10.3389/fragi.2024.1486281","url":null,"abstract":"<p><p>Aging is a universal physiological phenomenon, and chronic age-related diseases have become one of the leading causes of human mortality, accounting for nearly half of all deaths. Studies have shown that reducing the incidence of these diseases can not only extend lifespan but also promote healthy aging. In recent years, the potential role of non-histone high-mobility group proteins (HMGs) in the regulation of aging and lifespan has attracted widespread attention. HMGs play critical roles in cellular senescence and associated diseases through various pathways, encompassing multi-layered mechanisms involving protein interactions, molecular regulation, and chromatin dynamics. This review provides a comprehensive analysis of the interactions between HMG family proteins and senescence-associated secretory phenotype (SASP), chromatin structure, and histone modifications, offering a deeper exploration of the pivotal functions and impacts of HMGs in the aging process. Furthermore, we summarize recent findings on the contributions of HMG proteins to aging and age-related diseases. HMG proteins not only regulate senescence-associated inflammation through modulating the SASP but also influence genomic stability and cell fate decisions via interactions with chromatin and histones. Targeting HMG proteins holds great potential in delaying the progression of aging and its associated diseases. This review aims to provide a systematic overview of HMG proteins' roles in aging and to lay a solid foundation for future anti-aging drug development and therapeutic strategies. With the advancing understanding of the mechanisms by which HMGs regulate aging, developing therapeutic interventions targeting HMGs may emerge as a promising approach to extending lifespan and enhancing healthspan.</p>","PeriodicalId":73061,"journal":{"name":"Frontiers in aging","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11537863/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142592431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Impact of hearing rehabilitation programs on presbycusis management: a systematic review and meta-analysis of randomized controlled trials.","authors":"Zhanhang Zheng, Shuhong Qin, Ruilin Li, Wenjuan Wang, Chenxingzi Wu","doi":"10.3389/fragi.2024.1299964","DOIUrl":"10.3389/fragi.2024.1299964","url":null,"abstract":"<p><strong>Background: </strong>In the field of audiology, numerous studies have sought to understand and improve hearing rehabilitation programs for older adults afflicted with presbycusis. Despite this, the field lacks uniform standards pertaining to the intervention methods, frequency, and duration of such programs. These discrepancies have led to varying test results and inconsistent findings across multiple studies.</p><p><strong>Objective: </strong>This meta-analysis aimed to evaluate the efficacy of hearing rehabilitation programs in enhancing the utilization of hearing aids among older adults with presbycusis.</p><p><strong>Methods: </strong>We conducted a comprehensive exploration of PubMed, Embase, Cochrane Library, and Web of Science to identify randomized controlled trials assessing the role of hearing rehabilitation programs for patients with age-related hearing loss. The search period spanned from the inception of each database to September 12, 2024. Outcomes were synthesized using RevMan 5.4 software.</p><p><strong>Results: </strong>Eight studies met the inclusion criteria, involving 598 patients (290 in the intervention group and 308 in the control group). It was observed that hearing rehabilitation programs significantly diminished self-perceived hearing impairment [MD = -5.80, 95% CI = (-8.16, -3.44), <i>p</i> < 0.00001] and negative emotional states [MD = -1.66, 95% CI = (-3.02, -0.29), <i>p</i> = 0.02], while enhancing hearing aid utilization [MD = 0.22, 95% CI = (0.08, 0.36), <i>p</i> = 0.002]. Nonetheless, these programs did not significantly augment patients' satisfaction with their hearing aids [MD = 0.09, 95% CI = (-0.17, 0.26), <i>p</i> = 0.66].</p><p><strong>Conclusion: </strong>Hearing rehabilitation programs significantly improve hearing aid outcomes, reduce self-perceived hearing impairment, and alleviate negative emotional states in patients. However, the current body of evidence is insufficient to conclusively indicate that these programs enhance patient satisfaction with daily hearing aid usage.</p>","PeriodicalId":73061,"journal":{"name":"Frontiers in aging","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11532099/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142577381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in agingPub Date : 2024-10-17eCollection Date: 2024-01-01DOI: 10.3389/fragi.2024.1462569
Fahrul Nurkolis, Trianna Wahyu Utami, Aiman Idrus Alatas, Danar Wicaksono, Rudy Kurniawan, Satria Rafi Ratmandhika, Kartika Taufani Sukarno, Yehezkiel Gian Pradipta Pahu, Bonglee Kim, Trina Ekawati Tallei, Raymond Rubianto Tjandrawinata, Ananto Ali Alhasyimi, Reggie Surya, Helen Helen, Princella Halim, Adi Muradi Muhar, Rony Abdi Syahputra
{"title":"Can salivary and skin microbiome become a biodetector for aging-associated diseases? Current insights and future perspectives.","authors":"Fahrul Nurkolis, Trianna Wahyu Utami, Aiman Idrus Alatas, Danar Wicaksono, Rudy Kurniawan, Satria Rafi Ratmandhika, Kartika Taufani Sukarno, Yehezkiel Gian Pradipta Pahu, Bonglee Kim, Trina Ekawati Tallei, Raymond Rubianto Tjandrawinata, Ananto Ali Alhasyimi, Reggie Surya, Helen Helen, Princella Halim, Adi Muradi Muhar, Rony Abdi Syahputra","doi":"10.3389/fragi.2024.1462569","DOIUrl":"10.3389/fragi.2024.1462569","url":null,"abstract":"<p><p>Growth and aging are fundamental elements of human development. Aging is defined by a decrease in physiological activities and higher illness vulnerability. Affected by lifestyle, environmental, and hereditary elements, aging results in disorders including cardiovascular, musculoskeletal, and neurological diseases, which accounted for 16.1 million worldwide deaths in 2019. Stress-induced cellular senescence, caused by DNA damage, can reduce tissue regeneration and repair, promoting aging. The root cause of many age-related disorders is inflammation, encouraged by the senescence-associated secretory phenotype (SASP). Aging's metabolic changes and declining immune systems raise illness risk via promoting microbiome diversity. Stable, individual-specific skin and oral microbiomes are essential for both health and disease since dysbiosis is linked with periodontitis and eczema. Present from birth to death, the human microbiome, under the influence of diet and lifestyle, interacts symbiotically with the body. Poor dental health has been linked to Alzheimer's and Parkinson's diseases since oral microorganisms and systemic diseases have important interactions. Emphasizing the importance of microbiome health across the lifetime, this study reviews the understanding of the microbiome's role in aging-related diseases that can direct novel diagnosis and treatment approaches.</p>","PeriodicalId":73061,"journal":{"name":"Frontiers in aging","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11524912/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142559627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Prediction of COVID-19 in-hospital mortality in older patients using artificial intelligence: a multicenter study.","authors":"Massimiliano Fedecostante, Jacopo Sabbatinelli, Giuseppina Dell'Aquila, Fabio Salvi, Anna Rita Bonfigli, Stefano Volpato, Caterina Trevisan, Stefano Fumagalli, Fabio Monzani, Raffaele Antonelli Incalzi, Fabiola Olivieri, Antonio Cherubini","doi":"10.3389/fragi.2024.1473632","DOIUrl":"10.3389/fragi.2024.1473632","url":null,"abstract":"<p><strong>Background: </strong>Once the pandemic ended, SARS-CoV-2 became endemic, with flare-up phases. COVID-19 disease can still have a significant clinical impact, especially in older patients with multimorbidity and frailty.</p><p><strong>Objective: </strong>This study aims at evaluating the main characteristics associated to in-hospital mortality among data routinely collected upon admission to identify older patients at higher risk of death.</p><p><strong>Methods: </strong>The present study used data from Gerocovid-acute wards, an observational multicenter retrospective-prospective study conducted in geriatric and internal medicine wards in subjects ≥60 years old during the COVID-19 pandemic. Seventy-one routinely collected variables, including demographic data, living arrangements, smoking habits, pre-COVID-19 mobility, chronic diseases, and clinical and laboratory parameters were integrated into a web-based machine learning platform (Just Add Data Bio) to identify factors with the highest prognostic relevance. The use of artificial intelligence allowed us to avoid variable selection bias, to test a large number of models and to perform an internal validation.</p><p><strong>Results: </strong>The dataset was split into training and test sets, based on a 70:30 ratio and matching on age, sex, and proportion of events; 3,520 models were set out to train. The three predictive algorithms (optimized for performance, interpretability, or aggressive feature selection) converged on the same model, including 12 variables: pre-COVID-19 mobility, World Health Organization disease severity, age, heart rate, arterial blood gases bicarbonate and oxygen saturation, serum potassium, systolic blood pressure, blood glucose, aspartate aminotransferase, PaO2/FiO2 ratio and derived neutrophil-to-lymphocyte ratio.</p><p><strong>Conclusion: </strong>Beyond variables reflecting the severity of COVID-19 disease failure, pre-morbid mobility level was the strongest factor associated with in-hospital mortality reflecting the importance of functional status as a synthetic measure of health in older adults, while the association between derived neutrophil-to-lymphocyte ratio and mortality, confirms the fundamental role played by neutrophils in SARS-CoV-2 disease.</p>","PeriodicalId":73061,"journal":{"name":"Frontiers in aging","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11525005/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142559628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in agingPub Date : 2024-10-16eCollection Date: 2024-01-01DOI: 10.3389/fragi.2024.1490302
Marianna V Wrona, Rituparna Ghosh, Kaitlyn Coll, Connor Chun, Matthew J Yousefzadeh
{"title":"The 3 I's of immunity and aging: immunosenescence, inflammaging, and immune resilience.","authors":"Marianna V Wrona, Rituparna Ghosh, Kaitlyn Coll, Connor Chun, Matthew J Yousefzadeh","doi":"10.3389/fragi.2024.1490302","DOIUrl":"10.3389/fragi.2024.1490302","url":null,"abstract":"<p><p>As we age, our immune system's ability to effectively respond to pathogens declines, a phenomenon known as immunosenescence. This age-related deterioration affects both innate and adaptive immunity, compromising immune function and leading to chronic inflammation that accelerates aging. Immunosenescence is characterized by alterations in immune cell populations and impaired functionality, resulting in increased susceptibility to infections, diminished vaccine efficacy, and higher prevalence of age-related diseases. Chronic low-grade inflammation further exacerbates these issues, contributing to a decline in overall health and resilience. This review delves into the characteristics of immunosenescence and examines the various intrinsic and extrinsic factors contributing to immune aging and how the hallmarks of aging and cell fates can play a crucial role in this process. Additionally, it discusses the impact of sex, age, social determinants, and gut microbiota health on immune aging, illustrating the complex interplay of these factors in altering immune function. Furthermore, the concept of immune resilience is explored, focusing on the metrics for assessing immune health and identifying strategies to enhance immune function. These strategies include lifestyle interventions such as diet, regular physical activity, stress management, and the use of gerotherapeutics and other approaches. Understanding and mitigating the effects of immunosenescence are crucial for developing interventions that support robust immune responses in aged individuals.</p>","PeriodicalId":73061,"journal":{"name":"Frontiers in aging","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11521913/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142549309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in agingPub Date : 2024-10-09eCollection Date: 2024-01-01DOI: 10.3389/fragi.2024.1491389
Rocio Diaz Escarcega, Paul Marshall, Andrey S Tsvetkov
{"title":"G-quadruplex DNA and RNA in cellular senescence.","authors":"Rocio Diaz Escarcega, Paul Marshall, Andrey S Tsvetkov","doi":"10.3389/fragi.2024.1491389","DOIUrl":"https://doi.org/10.3389/fragi.2024.1491389","url":null,"abstract":"<p><p>Normal cells divide, are damaged, and are repaired across their lifetime. As cells age, they enter cellular senescence, characterized by a permanent state of cell-cycle arrest triggered by various stressors. The molecular mechanisms that regulate senescent phenotypes have been actively investigated over the last several decades; however, one area that has been neglected is how G-quadruplex (G4) DNA and RNA (G4-DNA and G4-RNA) mediate senescence. These non-canonical four-stranded DNA and RNA structures regulate most normative DNA and RNA-dependent processes, such as transcription, replication, and translation, as well as pathogenic mechanisms, including genomic instability and abnormal stress granule function. This review also highlights the contribution of G4s to sex differences in age-associated diseases and emphasizes potential translational approaches to target senescence and anti-aging mechanisms through G4 manipulation.</p>","PeriodicalId":73061,"journal":{"name":"Frontiers in aging","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11496277/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in agingPub Date : 2024-10-01eCollection Date: 2024-01-01DOI: 10.3389/fragi.2024.1460360
Maxim N Shokhirev, Daniel J Kramer, Janie Corley, Simon R Cox, Trinna L Cuellar, Adiv A Johnson
{"title":"CheekAge, a next-generation epigenetic buccal clock, is predictive of mortality in human blood.","authors":"Maxim N Shokhirev, Daniel J Kramer, Janie Corley, Simon R Cox, Trinna L Cuellar, Adiv A Johnson","doi":"10.3389/fragi.2024.1460360","DOIUrl":"https://doi.org/10.3389/fragi.2024.1460360","url":null,"abstract":"<p><p>While earlier first-generation epigenetic aging clocks were trained to estimate chronological age as accurately as possible, more recent next-generation clocks incorporate DNA methylation information more pertinent to health, lifestyle, and/or outcomes. Recently, we produced a non-invasive next-generation epigenetic clock trained using Infinium MethylationEPIC data from more than 8,000 diverse adult buccal samples. While this clock correlated with various health, lifestyle, and disease factors, we did not assess its ability to capture mortality. To address this gap, we applied CheekAge to the longitudinal Lothian Birth Cohorts of 1921 and 1936. Despite missing nearly half of its CpG inputs, CheekAge was significantly associated with mortality in this longitudinal blood dataset. Specifically, a change in one standard deviation corresponded to a hazard ratio (HR) of 1.21 (FDR <i>q</i> = 1.66e-6). CheekAge performed better than all first-generation clocks tested and displayed a comparable HR to the next-generation, blood-trained DNAm PhenoAge clock (HR = 1.23, <i>q</i> = 2.45e-9). To better understand the relative importance of each CheekAge input in blood, we iteratively removed each clock CpG and re-calculated the overall mortality association. The most significant effect came from omitting the CpG cg14386193, which is annotated to the gene <i>ALPK2</i>. Excluding this DNA methylation site increased the FDR value by nearly threefold (to 4.92e-06). We additionally performed enrichment analyses of the top annotated CpGs that impact mortality to better understand their associated biology. Taken together, we provide important validation for CheekAge and highlight novel CpGs that underlie a newly identified mortality association.</p>","PeriodicalId":73061,"journal":{"name":"Frontiers in aging","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11473594/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142482314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in agingPub Date : 2024-09-24eCollection Date: 2024-01-01DOI: 10.3389/fragi.2024.1389610
Javier Mesas-Fernández, Jordi Tous-Pallarès, Ivette Margarita Espinoza-Díaz
{"title":"Systematic review in relation to support of diversity in nursing homes.","authors":"Javier Mesas-Fernández, Jordi Tous-Pallarès, Ivette Margarita Espinoza-Díaz","doi":"10.3389/fragi.2024.1389610","DOIUrl":"https://doi.org/10.3389/fragi.2024.1389610","url":null,"abstract":"<p><strong>Introduction: </strong>Given the increasing global population of older adults, it is essential and inevitable that healthcare centers and nursing homes address and accommodate diversity in their support systems as interventions for healthy aging. The active aging and the inclusion of all people regardless of their religion, origin, and/or sexual orientation is essential to create a climate of safety. Discrimination must be addressed from all angles, at the social level, at the business level and by all workers in nursing homes.</p><p><strong>Methodology and results: </strong>This study provides a comprehensive review of existing literature to systematize information on diversity among older adults in healthcare centers and nursing homes. Out of 1.458 articles identified, 10 were analyzed in depth, revealing that addressing diversity among older adults is crucial to overall mental and physical healthy aging. The findings underscore the need for a multidisciplinary approach and effective management through the Person-Centered Care Model (PCCM).</p><p><strong>Discussion and conclusion: </strong>This study highlights the critical role of the Person-Centered Care Model (PCCM) in addressing diversity in aging needs. It highlights the necessity of tailoring care based on individual life histories and experiences. Additionally, it calls for the implementation of inclusive policies in nursing homes and emphasizes the need for professional training on diversity to ensure these facilities are safe and supportive for all residents.</p>","PeriodicalId":73061,"journal":{"name":"Frontiers in aging","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11458523/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in agingPub Date : 2024-09-24eCollection Date: 2024-01-01DOI: 10.3389/fragi.2024.1442323
M Victoria Delpino, Jorge Quarleri
{"title":"Aging mitochondria in the context of SARS-CoV-2: exploring interactions and implications.","authors":"M Victoria Delpino, Jorge Quarleri","doi":"10.3389/fragi.2024.1442323","DOIUrl":"https://doi.org/10.3389/fragi.2024.1442323","url":null,"abstract":"<p><p>The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has presented global challenges with a diverse clinical spectrum, including severe respiratory complications and systemic effects. This review explores the intricate relationship between mitochondrial dysfunction, aging, and obesity in COVID-19. Mitochondria are vital for cellular energy provision and resilience against age-related macromolecule damage accumulation. They manage energy allocation in cells, activating adaptive responses and stress signals such as redox imbalance and innate immunity activation. As organisms age, mitochondrial function diminishes. Aging and obesity, linked to mitochondrial dysfunction, compromise the antiviral response, affecting the release of interferons, and worsening COVID-19 severity. Furthermore, the development of post-acute sequelae of SARS-CoV-2 infection (PASC), also known as long COVID has been associated with altered energy metabolism, and chronic immune dysregulation derived from mitochondrial dysfunction. Understanding the interplay between mitochondria, aging, obesity, and viral infections provides insights into COVID-19 pathogenesis. Targeting mitochondrial health may offer potential therapeutic strategies to mitigate severe outcomes and address long-term consequences in infected individuals.</p>","PeriodicalId":73061,"journal":{"name":"Frontiers in aging","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11458564/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in agingPub Date : 2024-09-20eCollection Date: 2024-01-01DOI: 10.3389/fragi.2024.1365716
Dilara Yılmaz, Amit Singh, Esther Wehrle, Gisela A Kuhn, Neashan Mathavan, Ralph Müller
{"title":"Unveiling frailty: comprehensive and sex-specific characterization in prematurely aging PolgA mice.","authors":"Dilara Yılmaz, Amit Singh, Esther Wehrle, Gisela A Kuhn, Neashan Mathavan, Ralph Müller","doi":"10.3389/fragi.2024.1365716","DOIUrl":"10.3389/fragi.2024.1365716","url":null,"abstract":"<p><p>Frailty, a geriatric syndrome, is assessed using the frailty phenotype (FP) and frailty index (FI). While these approaches have been applied to aging mice, their effectiveness in prematurely aging mouse models such as PolgA<sup>D257A/D257A</sup> (PolgA) has not been completely explored. We demonstrated that frailty became evident in PolgA mice around 40 weeks, validated through body weight loss, reduced walking speed, decreased physical activity, and weaker grip strength. Moreover, we also identified sex differences in these mice with females exhibiting slightly more physical decline compared to males. Frailty prevalence in PolgA mice at 40 weeks parallels that observed in naturally aging mice at 27 months and aging humans at 65-70 years. These findings contribute to understanding frailty onset and sex-specific patterns in this prematurely aging mouse model, emphasizing the significance of the PolgA mouse model in investigating aging and related disorders.</p>","PeriodicalId":73061,"journal":{"name":"Frontiers in aging","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11449839/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142382621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}